亮晴控股(08603)发布公告，公司已于2025年12月8日根据主板上市规则第9B章向联交所提交转板上市申 请。转板上市将不会涉及本公司发行任何新股份。 另一方面，董事会认为主板上市将拓宽本公司接触更广泛投资者群体的渠道，包括机构投资者、专业投 资者及国际参与者，从而扩展及分散股东基础。此次转板上市亦预期将提升本公司的融资灵活性，使其 能以更优惠的条件获取更多元化的债务融资选项。此举将支持资本结构的优化，并提供更具策略性的财 务管理空间。董事会认为转板上市将对本集团的可持续增长与长远发展产生积极作用，从而巩固其在医 学美容领域的领先地位，并为本公司及其股东创造持久价值。 董事会相信，凭借主板较大的总市值、较高的交易量及相对较高的国际知名度，从GEM转往主板上市 将大幅提升本公司的企业形象及公众认可度。作为香港一家成熟的医学美容服务供应商，本集团认为， 主板更严格的上市要求及其代表的优质地位是对自身营运业绩与市场地位的有力认可。此声誉的提升预 期将增强本公司吸引及留住优质客户、商业伙伴与人才的能力，同时亦有助更有效地把握新商机。 董事会认为转板上市将对本集团的可持续增长与长远发展产生积极作用，从而巩固其在医学美 ...

Core Viewpoint - The company has submitted an application for a transfer to the Main Board of the Hong Kong Stock Exchange, which is expected to enhance its corporate image and public recognition without issuing new shares [1] Group 1: Benefits of Main Board Listing - The transfer to the Main Board is anticipated to significantly improve the company's corporate image and public recognition due to the larger market capitalization, higher trading volume, and greater international visibility associated with the Main Board [1] - The stricter listing requirements of the Main Board are seen as a strong recognition of the company's operational performance and market position, which is expected to enhance its ability to attract and retain high-quality clients, business partners, and talent [1] - The listing on the Main Board is expected to broaden the company's access to a wider range of investors, including institutional and international participants, thereby expanding and diversifying its shareholder base [1] Group 2: Financial Flexibility and Growth - The company anticipates that the Main Board listing will enhance its financing flexibility, allowing it to obtain more diversified debt financing options under more favorable conditions [1] - This move is expected to support the optimization of the company's capital structure and provide more strategic financial management space [1] - The board believes that the transfer to the Main Board will have a positive impact on the company's sustainable growth and long-term development, reinforcing its leading position in the medical beauty sector and creating lasting value for the company and its shareholders [2]

Group 1 - The core announcement is that Bright Sunny Holdings (stock code: 8603) plans to raise approximately HKD 50 million through the placement of new shares, issuing 18,920,000 shares at a price of HKD 2.61, which represents a discount of about 17.9% from the previous closing price of HKD 3.18 [1] - The placement shares account for approximately 2.4% of the existing issued share capital and will represent about 2.3% of the enlarged share capital after completion [1] - The funds raised will be used to supplement general working capital, including employee costs, rent expenses, and other business and company expenditures [1] Group 2 - Bright Sunny Holdings primarily provides medical beauty services in Hong Kong, operating medical beauty centers and selling skincare products [1]